Bariatric embolization of the gastric arteries for the treatment of obesity

Clifford R. Weiss; Andrew J. Gunn; Charles Y. Kim; Ben E. Paxton; Dara L. Kraitchman; Aravind Arepally

doi:10.1016/j.jvir.2015.01.017

Bariatric embolization of the gastric arteries for the treatment of obesity

Clifford R. Weiss, Andrew J. Gunn, Charles Y. Kim, Ben E. Paxton, Dara L. Kraitchman, Aravind Arepally

School of Medicine

Research output: Contribution to journal › Review article › peer-review

22 Scopus citations

Abstract

Obesity is a public health epidemic in the United States that results in significant morbidity, mortality, and cost to the health care system. Despite advancements in therapeutic options for patients receiving bariatric procedures, the number of overweight and obese individuals continues to increase. Therefore, complementary or alternative treatments to lifestyle changes and surgery are urgently needed. Embolization of the left gastric artery, or bariatric arterial embolization (BAE), has been shown to modulate body weight in animal models and early clinical studies. If successful, BAE represents a potential minimally invasive approach offered by interventional radiologists to treat obesity. The purpose of the present review is to introduce the interventional radiologist to BAE by presenting its physiologic and anatomic bases, reviewing the preclinical and clinical data, and discussing current and future investigations.

Original language	English (US)
Pages (from-to)	613-624
Number of pages	12
Journal	Journal of Vascular and Interventional Radiology
Volume	26
Issue number	5
DOIs	https://doi.org/10.1016/j.jvir.2015.01.017
State	Published - May 1 2015

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jvir.2015.01.017

Cite this

@article{10c540becbd946d5b8eb698c0232c4fe,

title = "Bariatric embolization of the gastric arteries for the treatment of obesity",

abstract = "Obesity is a public health epidemic in the United States that results in significant morbidity, mortality, and cost to the health care system. Despite advancements in therapeutic options for patients receiving bariatric procedures, the number of overweight and obese individuals continues to increase. Therefore, complementary or alternative treatments to lifestyle changes and surgery are urgently needed. Embolization of the left gastric artery, or bariatric arterial embolization (BAE), has been shown to modulate body weight in animal models and early clinical studies. If successful, BAE represents a potential minimally invasive approach offered by interventional radiologists to treat obesity. The purpose of the present review is to introduce the interventional radiologist to BAE by presenting its physiologic and anatomic bases, reviewing the preclinical and clinical data, and discussing current and future investigations.",

author = "Weiss, {Clifford R.} and Gunn, {Andrew J.} and Kim, {Charles Y.} and Paxton, {Ben E.} and Kraitchman, {Dara L.} and Aravind Arepally",

note = "Funding Information: C.R.W. received funding for this research from Merit Medical (South Jordan, Utah), Siemens (Forchheim, Germany), and the National Institutes of Health (NIH). D.L.K. received funding for this research from Siemens and NIH and has patent ownership or part ownership in imaging visible beads. A.A. received funding for this research from Siemens and Merit Medical, is a paid consultant for Surefire Medical (Westminster, Colorado), W.L. Gore & Associates (Flagstaff, Arizona), and ENDOBAR (New York, New York), and has patent ownership or part ownership in a Surefire catheter. None of the other authors have identified a conflict of interest. Review Article Publisher Copyright: {\textcopyright} 2015 SIR.",

year = "2015",

month = may,

day = "1",

doi = "10.1016/j.jvir.2015.01.017",

language = "English (US)",

volume = "26",

pages = "613--624",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Bariatric embolization of the gastric arteries for the treatment of obesity

AU - Weiss, Clifford R.

AU - Gunn, Andrew J.

AU - Kim, Charles Y.

AU - Paxton, Ben E.

AU - Kraitchman, Dara L.

AU - Arepally, Aravind

N1 - Funding Information: C.R.W. received funding for this research from Merit Medical (South Jordan, Utah), Siemens (Forchheim, Germany), and the National Institutes of Health (NIH). D.L.K. received funding for this research from Siemens and NIH and has patent ownership or part ownership in imaging visible beads. A.A. received funding for this research from Siemens and Merit Medical, is a paid consultant for Surefire Medical (Westminster, Colorado), W.L. Gore & Associates (Flagstaff, Arizona), and ENDOBAR (New York, New York), and has patent ownership or part ownership in a Surefire catheter. None of the other authors have identified a conflict of interest. Review Article Publisher Copyright: © 2015 SIR.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Obesity is a public health epidemic in the United States that results in significant morbidity, mortality, and cost to the health care system. Despite advancements in therapeutic options for patients receiving bariatric procedures, the number of overweight and obese individuals continues to increase. Therefore, complementary or alternative treatments to lifestyle changes and surgery are urgently needed. Embolization of the left gastric artery, or bariatric arterial embolization (BAE), has been shown to modulate body weight in animal models and early clinical studies. If successful, BAE represents a potential minimally invasive approach offered by interventional radiologists to treat obesity. The purpose of the present review is to introduce the interventional radiologist to BAE by presenting its physiologic and anatomic bases, reviewing the preclinical and clinical data, and discussing current and future investigations.

AB - Obesity is a public health epidemic in the United States that results in significant morbidity, mortality, and cost to the health care system. Despite advancements in therapeutic options for patients receiving bariatric procedures, the number of overweight and obese individuals continues to increase. Therefore, complementary or alternative treatments to lifestyle changes and surgery are urgently needed. Embolization of the left gastric artery, or bariatric arterial embolization (BAE), has been shown to modulate body weight in animal models and early clinical studies. If successful, BAE represents a potential minimally invasive approach offered by interventional radiologists to treat obesity. The purpose of the present review is to introduce the interventional radiologist to BAE by presenting its physiologic and anatomic bases, reviewing the preclinical and clinical data, and discussing current and future investigations.

UR - http://www.scopus.com/inward/record.url?scp=84928827275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928827275&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2015.01.017

DO - 10.1016/j.jvir.2015.01.017

M3 - Review article

C2 - 25777177

AN - SCOPUS:84928827275

SN - 1051-0443

VL - 26

SP - 613

EP - 624

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 5

ER -

Bariatric embolization of the gastric arteries for the treatment of obesity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this